BETRF
BetterLife Pharma Inc.
Set alert
0.18 USD 0.00 0.00%
0.18 Day range 0.18
0.028 52-week range 0.331
- YTD
- +462.50%
- 1 year
- +275.00%
- Open
- 0.18
- Prev close
- 0.18
- Mkt cap
- 111.24M
- Vol
- 3.00K
- Avg vol
- 138.06K
- EPS
- -0.02
- P/E
- 0.00
More statistics
- Low
- 0.18
- High
- 0.18
- Earnings
- Jan 3, 2025
Next earnings
Jan 3, 2025
Expected Jan 3, 2025. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 3, 2025 | Oct 1, 2024 | 0.00 | — | — | — |
| Sep 25, 2024 | Jul 1, 2024 | 0.00 | -0.01 | — | — |
| Jun 27, 2024 | Apr 1, 2024 | 0.00 | -0.01 | — | — |
| May 29, 2024 | Jan 1, 2024 | 0.00 | -0.01 | — | — |
| Dec 29, 2023 | Oct 1, 2023 | 0.00 | 0.00 | — | — |
| Sep 27, 2023 | Jul 1, 2023 | 0.00 | -0.01 | — | — |
News
- BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm
- BetterLife Pharma Appoints Professor Richard B. Lipton as Co-Chair of its Scientific Advisory Board
- BetterLife Pharma Appoints Sheila Leitzinger as Head of Clinical Operations
- BetterLife Pharma Inc. (OTCMKTS:BETRF) Stock Short Interest Report for September
- BetterLife Pharma Establishes Scientific Advisory Board for Headache Program; Professor Peter Goadsby Appointed Co-Chair
- BetterLife Pharma Addresses Notice of Civil Claim Filed by Steven Sangha
- BetterLife Pharma Announces Rescheduling and Reclassification of Annual General Meeting to Annual General and Special Meeting
- BetterLife Pharma Inc. (OTCMKTS:BETRF) Sees Large Decrease in Short Interest
- BetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit Committee
- BetterLife Pharma Appoints Mahan Chehrenama, DO, as Chief Medical Officer
Your note
Sign in to keep a note on BETRF — it syncs with the Stock Master app.